This week, Caroline Hyde sat down with Allergan Chief Executive Brent Saunders for a wide-ranging interview as part of our CEO Spotlight Series. Saunders discussed high drug prices, selling Allergan to rival AbbVie for $63 billion, why his best career decision was taking a "huge" pay cut and what's coming next for him after the AbbVie deal.

Fiat Currency is Having a Midlife Crisis
27:03

Serial SPAC-er Betsy Cohen Finds Her Seventh Target
28:20

Companies Have Lost the Distinction Between Data and Information
27:26